Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pipeline Analysis

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1753130

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1753130

Morquio Syndrome Drugs

PUBLISHED:
PAGES: 467 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Morquio Syndrome Drugs Market to Reach US$3.0 Million by 2030

The global market for Morquio Syndrome Drugs estimated at US$1.6 Million in the year 2024, is expected to reach US$3.0 Million by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$1.5 Million by the end of the analysis period. Growth in the Hematopoietic Stem Cell Therapy segment is estimated at 13.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$436.0 Thousand While China is Forecast to Grow at 14.8% CAGR

The Morquio Syndrome Drugs market in the U.S. is estimated at US$436.0 Thousand in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$613.8 Thousand by the year 2030 trailing a CAGR of 14.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.2% and 9.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.7% CAGR.

Global Morquio Syndrome Drugs Market - Key Trends & Drivers Summarized

What Is Morquio Syndrome and Why Are Targeted Therapies Critical?

Morquio syndrome, also known as Mucopolysaccharidosis type IV (MPS IV), is a rare autosomal recessive lysosomal storage disorder caused by deficiencies in the GALNS or GLB1 enzymes. This results in the accumulation of glycosaminoglycans (GAGs) in the body, leading to severe skeletal abnormalities, joint dysfunction, vision and hearing impairment, and cardiopulmonary complications. Given the progressive nature and multisystem impact of the disease, drug treatment focuses on enzyme replacement therapy (ERT) and supportive care aimed at slowing progression and managing symptoms.

The ultra-rare status of Morquio syndrome has made it a key focus of orphan drug development efforts. ERT-particularly with elosulfase alfa-has emerged as the primary treatment to address the underlying enzyme deficiency in MPS IV-A. While it does not reverse existing skeletal damage, ERT improves endurance, reduces GAG accumulation, and may enhance respiratory and cardiovascular function over time. In the absence of curative options, timely diagnosis and consistent therapy are essential to prolong mobility and improve quality of life.

What Innovations Are Advancing Therapeutic Efficacy and Access?

Current innovations are centered on improving the delivery, bioavailability, and long-term efficacy of enzyme replacement therapies. Researchers are exploring modified enzymes with longer half-lives and enhanced tissue penetration-especially targeting the skeletal system, which remains poorly responsive to conventional ERT due to vascular limitations. Intrathecal administration methods and fusion protein technologies are being investigated to enhance enzyme access to bone and central nervous system tissues.

Gene therapy is another area of active research, aiming to introduce functional copies of the GALNS or GLB1 gene using viral vectors. Preclinical studies show promise in achieving systemic enzyme expression with potentially fewer dosing requirements. Additionally, substrate reduction therapy (SRT) and chaperone therapy are being explored as adjunct or alternative approaches. These innovations are being enabled by advancements in molecular diagnostics, patient registries, and clinical trial infrastructure for rare diseases.

Which Patient Populations and Geographies Are Driving Demand for Treatment?

Pediatric patients make up the majority of Morquio syndrome cases, with diagnosis typically occurring between ages two and six. Early treatment initiation is associated with better outcomes, particularly in maintaining mobility and slowing cardiopulmonary decline. Demand is most concentrated in North America and Europe, where newborn screening programs, access to genetic testing, and availability of orphan drug reimbursement frameworks support treatment initiation.

In Latin America, the Middle East, and parts of Asia-Pacific, underdiagnosis remains a challenge due to limited awareness and diagnostic infrastructure. However, advocacy groups and international collaborations are increasing patient identification and access to therapies in these regions. The increasing availability of genetic testing and biomarker-based diagnosis is helping identify more patients at earlier stages, driving long-term demand for therapies and supportive care.

The Growth in the Morquio Syndrome Drugs Market Is Driven by Several Factors…

The growth in the Morquio syndrome drugs market is driven by several factors including rising awareness of rare lysosomal storage diseases, improvements in early diagnostic methods, and ongoing innovation in enzyme and gene therapies. Market expansion is supported by orphan drug incentives, favorable regulatory frameworks, and increasing inclusion of Morquio therapies in national rare disease programs. Advances in biomarker monitoring, drug delivery technologies, and real-world data collection are improving clinical outcomes and expanding patient reach. As healthcare systems prioritize earlier intervention and long-term disease management for ultra-rare disorders, demand for novel and more effective Morquio syndrome therapies continues to rise globally.

SCOPE OF STUDY:

The report analyzes the Morquio Syndrome Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy, Other Treatments); Disease Type (Morquio A, Morquio B); Form (Solid Form, Liquid Form); Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abeona Therapeutics Inc.
  • Alexion Pharmaceuticals Inc.
  • Amgen Inc.
  • ArmaGen
  • BioMarin Pharmaceutical Inc.
  • Concert Pharmaceuticals Inc.
  • Genzyme Corporation
  • GREEN CROSS Corporation
  • JCR Pharmaceuticals Co., Ltd.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Regenxbio Inc.
  • Sangamo Therapeutics
  • Sanofi
  • Shire plc
  • Takeda Pharmaceutical Company Limited
  • Ultragenyx Pharmaceutical Inc.
  • Vtesse Inc.
  • Zymenex A/S

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP35388

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Morquio Syndrome Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Diagnosis Rates and Improved Genetic Screening Drive Early Identification of Morquio Syndrome
    • Expansion of Orphan Drug Designations Spurs R&D in Enzyme Replacement Therapies (ERTs)
    • OEM Focus on Long-Term Disease Management Supports Development of Targeted Therapies
    • Increased Awareness Campaigns and Advocacy Efforts Strengthen Early Intervention and Drug Uptake
    • Growing Collaboration Between Biopharma Firms and Rare Disease Foundations Enhances R&D Funding
    • Advancements in Biomarker Development Improve Monitoring of Drug Efficacy in MPS IV Patients
    • Push for Home Infusion and Outpatient Administration Models Enhances Treatment Accessibility
    • Pipeline Expansion of Novel Therapeutic Candidates Supports Long-Term Market Outlook
    • Rising Demand for Personalized Medicine Approaches Fuels Development of Genotype-Specific Treatments
    • Global Expansion of Rare Disease Registries Improves Epidemiological Data and Market Targeting
    • OEM Innovation in Chaperone and Gene Therapies Expands Therapeutic Options for Morquio Syndrome
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Morquio Syndrome Drugs Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Morquio Syndrome Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Enzyme Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Enzyme Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Enzyme Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hematopoietic Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hematopoietic Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hematopoietic Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Morquio A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Morquio A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Morquio A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Morquio B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Morquio B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Morquio B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Solid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Solid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Solid Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Liquid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Liquid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Liquid Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • JAPAN
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • CHINA
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • EUROPE
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Morquio Syndrome Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • FRANCE
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 101: France Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • GERMANY
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 137: UK Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Morquio Syndrome Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • INDIA
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 212: India Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Morquio Syndrome Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Morquio Syndrome Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Morquio Syndrome Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030
  • AFRICA
    • Morquio Syndrome Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Morquio Syndrome Drugs by Treatment - Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Morquio Syndrome Drugs by Treatment - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Morquio Syndrome Drugs by Distribution Channel - Online Pharmacies, Retail Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Morquio Syndrome Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Retail Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Morquio Syndrome Drugs by Disease Type - Morquio A and Morquio B Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Morquio Syndrome Drugs by Disease Type - Percentage Breakdown of Value Sales for Morquio A and Morquio B for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Morquio Syndrome Drugs by Form - Solid Form and Liquid Form Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Morquio Syndrome Drugs by Form - Percentage Breakdown of Value Sales for Solid Form and Liquid Form for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!